Document Detail


Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing.
MedLine Citation:
PMID:  19840572     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
External or internal shocks administered to terminate ventricular arrhythmias as a part of electrophysiology or implantable cardioverter-defibrillator testing, can inadvertently cardiovert atrial fibrillation (AF). Moreover, anticoagulation therapy is often withheld in these patients in anticipation of an invasive procedure. The risk of embolic events during these procedures has not been well described. Accordingly, the present study was a prospective evaluation of the incidence of left atrial (LA) thrombus and AF cardioversion among patients undergoing ventricular arrhythmia assessment. Transesophageal echocardiography was routinely performed on 44 consecutive patients in AF with subtherapeutic anticoagulation undergoing electrophysiology or implantable cardioverter-defibrillator testing. Arrhythmia induction was not performed when LA thrombus was present. The incidence and clinical predictors of thrombus, the inadvertent cardioversion of AF, and adverse events related to the procedure were assessed during the subsequent 4 to 6 weeks. Left atrial thrombus was observed in 12 patients (27%). Sinus rhythm was restored in 29 patients (91%), at least transiently, who underwent testing with a shock delivered. No adverse neurologic or hemorrhagic complications were observed. Univariate analysis identified no predictors of LA thrombus or cardioversion to sinus rhythm. In conclusion, LA thrombus and cardioversion to sinus rhythm are common among patients with AF undergoing an evaluation of ventricular arrhythmias. Transesophageal echocardiography performed before the procedure in patients with subtherapeutic anticoagulation is warranted to minimize embolic complications. This strategy appears to be a safe method to guide diagnostic testing in this patient population.
Authors:
Rory Priester; Troy Bunting; Bruce Usher; Salvatore Chiaramida; Marian H Taylor; David Gregg; J Lacy Sturdivant; Robert B Leman; J Marcus Wharton; Michael R Gold
Publication Detail:
Type:  Journal Article     Date:  2009-09-16
Journal Detail:
Title:  The American journal of cardiology     Volume:  104     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-20     Completed Date:  2009-11-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1256-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Medical University of South Carolina, Charleston, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / therapeutic use
Atrial Fibrillation / therapy*
Defibrillators, Implantable
Echocardiography, Transesophageal*
Electric Countershock / methods*
Electrophysiologic Techniques, Cardiac
Female
Heart Atria / ultrasonography*
Humans
Male
Prospective Studies
Thrombosis / prevention & control,  ultrasonography*
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosc...
Next Document:  Use of low molecular weight Heparin in pregnant women with mechanical heart valves.